The global market for Crohn's disease is expected to grow at a compound annual growth rate of 2.84 percent from 2014 to 2019, according to a Market Research report.
Key vendors in the market include:
• AbbVie
• Astra Zeneca
• Biogen Idec
• Johnson & Johnson
• Takeda Pharmaceutical
• UCB